Gain Therapeutics (NASDAQ:GANX) stock is falling on Friday following the pricing of its shares in a public offering.This public offering has Gain Therapeutics selling 7,116,547 shares and pre-funded warrants for 1,031,602 shares. The shares are being sold for $1.35 each with the warrants having the same price minus $0.0001.The pre-funded warrants in this offering are exercisable immediately after being issued. They have an exercise price of $0.0001.Gain Therapeutics is also offering underwriters the option ...